Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012



Summary



GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012" provides data on the Irritable Bowel Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Irritable Bowel Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Irritable Bowel Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Irritable Bowel Syndrome 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Irritable Bowel Syndrome 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Irritable Bowel Syndrome Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Astellas Pharma Inc. 34
Clinical Trial Overview of Astellas Pharma Inc. 34
Salix Pharmaceuticals, Inc. 35
Clinical Trial Overview of Salix Pharmaceuticals, Inc. 35
Almirall, S.A. 36
Clinical Trial Overview of Almirall, S.A. 36
Sucampo Pharmaceuticals, Inc. 37
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 37
Lexicon Pharmaceuticals, Inc. 38
Clinical Trial Overview of Lexicon Pharmaceuticals, Inc. 38
Ironwood Pharmaceuticals, Inc. 39
Clinical Trial Overview of Ironwood Pharmaceuticals, Inc. 39
Yakult Honsha Co., Ltd. 40
Clinical Trial Overview of Yakult Honsha Co., Ltd. 40
AGI Therapeutics plc 41
Clinical Trial Overview of AGI Therapeutics plc 41
Tioga Pharmaceuticals, Inc. 42
Clinical Trial Overview of Tioga Pharmaceuticals, Inc. 42
Dynogen Pharmaceuticals, Inc. 43
Clinical Trial Overview of Dynogen Pharmaceuticals, Inc. 43
SOFAR SPA 44
Clinical Trial Overview of SOFAR SPA 44
Danone Research B.V. 45
Clinical Trial Overview of Danone Research B.V. 45
Novartis AG 46
Clinical Trial Overview of Novartis AG 46
Forest Laboratories, Inc. 48
Clinical Trial Overview of Forest Laboratories, Inc. 48
Ono Pharmaceutical Co., Ltd. 49
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 49
Alizyme plc 50
Clinical Trial Overview of Alizyme plc 50
Laboratoires Mayoly Spindler 51
Clinical Trial Overview of Laboratoires Mayoly Spindler 51
Trine Pharmaceuticals, Inc. 52
Clinical Trial Overview of Trine Pharmaceuticals, Inc. 52
Ardeypharm GmbH 53
Clinical Trial Overview of Ardeypharm GmbH 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
Mayo Clinic 54
Clinical Trial Overview of Mayo Clinic 54
The University of North Carolina 55
Clinical Trial Overview of The University of North Carolina 55
Maastricht University Medical Center 56
Clinical Trial Overview of Maastricht University Medical Center 56
Baylor College of Medicine 57
Clinical Trial Overview of Baylor College of Medicine 57
Sahlgrenska University Hospital 58
Clinical Trial Overview of Sahlgrenska University Hospital 58
Chinese University of Hong Kong 59
Clinical Trial Overview of Chinese University of Hong Kong 59
Karolinska Institutet 60
Clinical Trial Overview of Karolinska Institutet 60
Academic Medical Centre 61
Clinical Trial Overview of Academic Medical Centre 61
Cedars-Sinai Medical Center 62
Clinical Trial Overview of Cedars-Sinai Medical Center 62
University of Florida 63
Clinical Trial Overview of University of Florida 63
Medical College of Wisconsin 64
Clinical Trial Overview of Medical College of Wisconsin 64
National University Hospital 65
Clinical Trial Overview of National University Hospital 65
Penn State University 66
Clinical Trial Overview of Penn State University 66
UMC Utrecht 67
Clinical Trial Overview of UMC Utrecht 67
University of Missouri 68
Clinical Trial Overview of University of Missouri 68
University of Washington 69
Clinical Trial Overview of University of Washington 69
McGill University Health Center 70
Clinical Trial Overview of McGill University Health Center 70
University of California, Los Angeles 71
Clinical Trial Overview of University of California, Los Angeles 71
University of Southern Denmark 72
Clinical Trial Overview of University of Southern Denmark 72
Meir Medical Center 73
Clinical Trial Overview of Meir Medical Center 73
Five Key Clinical Profiles 74
Appendix 124
Abbreviations 124
Definitions 124
Research Methodology 125
Secondary Research 125
About GlobalData 126
Contact Us 126
Disclaimer 126
Source 127
List of Tables

List of Tables
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Irritable Bowel Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Irritable Bowel Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Irritable Bowel Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Irritable Bowel Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14
Irritable Bowel Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Irritable Bowel Syndrome Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Irritable Bowel Syndrome Therapeutics Clinical Trials, G7 Countries, 2012* 17
Irritable Bowel Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Irritable Bowel Syndrome Therapeutics Clinical Trials, E7 Countries, 2012* 19
Irritable Bowel Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Irritable Bowel Syndrome Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Irritable Bowel Syndrome Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Irritable Bowel Syndrome Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 33
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 34
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals, Inc., 2012* 35
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2012* 36
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2012* 37
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Lexicon Pharmaceuticals, Inc., 2012* 38
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ironwood Pharmaceuticals, Inc., 2012* 39
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Yakult Honsha Co., Ltd., 2012* 40
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by AGI Therapeutics plc, 2012* 41
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Tioga Pharmaceuticals, Inc., 2012* 42
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Dynogen Pharmaceuticals, Inc., 2012* 43
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by SOFAR SPA, 2012* 44
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Danone Research B.V., 2012* 45
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 46
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2012* 48
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2012* 49
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Alizyme plc, 2012* 50
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Mayoly Spindler, 2012* 51
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Trine Pharmaceuticals, Inc., 2012* 52
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ardeypharm GmbH, 2012* 53
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 54
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina, 2012* 55
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012* 56
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2012* 57
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2012* 58
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012* 59
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2012* 60
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 61
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012* 62
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012* 63
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2012* 64
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2012* 65
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2012* 66
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012* 67
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2012* 68
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2012* 69
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2012* 70
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 71
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern Denmark, 2012* 72
Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Meir Medical Center, 2012* 73
List of Figures

List of Figures
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Irritable Bowel Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Irritable Bowel Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Irritable Bowel Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Irritable Bowel Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14
Irritable Bowel Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15
Irritable Bowel Syndrome Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Irritable Bowel Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Irritable Bowel Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Irritable Bowel Syndrome Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Irritable Bowel Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
GlobalData Methodology 125

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Enabling Technological Platforms for Lab-on-Chip Applications  (Technical Insights)

Enabling Technological Platforms for Lab-on-Chip Applications (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

6 Dimensional Assessment of Lab on a Chip Innovation Landscape A growing trend towards miniaturizing laboratory practices has been a major driving force behind the steady increase of innovations in the ...

Global Proteomics Market

Global Proteomics Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of ...

Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018

Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

Over the years, the molecular spectroscopy market, comprising instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the numbe ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.